Evidence map›Paper›PMID 39229567›Full record

ReviewAnnals of gastroenterological surgery2024

Long-term outcomes of treatment for achalasia: Laparoscopic Heller myotomy versus POEM.

Naoko Fukushima, Takahiro Masuda, Kazuto Tsuboi, Jun Watanabe, Fumiaki Yano

Abstract readReview
In one paragraph

Review in Annals of gastroenterological surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Naoko FukushimaDepartment of Surgery The Jikei University School of Medicine Tokyo Japan.ORCID https://orcid.org/0000-0002-7656-3198
Takahiro MasudaDepartment of Surgery The Jikei University School of Medicine Tokyo Japan.
Kazuto TsuboiDepartment of Surgery The Jikei University School of Medicine Tokyo Japan.ORCID https://orcid.org/0000-0002-8126-431X
Jun WatanabeDivision of Gastroenterological, General and Transplant Surgery, Department of Surgery Jichi Medical University Shimotsuke Tochigi Japan.
Fumiaki YanoDepartment of Surgery The Jikei University School of Medicine Tokyo Japan.ORCID https://orcid.org/0000-0001-6682-4166

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Achalasia is a rare esophageal motility disorder characterized by nonrelaxation of the lower esophageal sphincter. Laparoscopic Heller myotomy (LHM) is the gold standard treatment for achalasia. Peroral endoscopic myotomy (POEM), a less invasive treatment, is performed extensively, and the selection of the intervention method remains debatable to date. In addition to the availability of extensive studies on short-term outcomes, recent studies on the long-term outcomes of LHM and POEM have shown similar clinical success after 5 y of follow-up. However, gastroesophageal reflux disease (GERD) was more common in patients who had undergone POEM than in those who had undergone LHM. Moreover, existing studies have compared treatment outcomes in various disease states. Some studies have suggested that POEM is superior to LHM for patients with type III achalasia because POEM allows for a longer myotomy. Research on treatment for sigmoid types is currently in progress. However, the long-term results comparing LHD and POEM are insufficient, and the best treatment remains controversial. Further research is needed, and treatment options should be discussed with patients and tailored to their individual needs and pathologies.

Indexed as

achalasiagastroesophageal reflux diseaselaparoscopic Heller myotomyperoral endoscopic myotomy

Identifiers

PMID39229567
PMCPMC11368501

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.